Baird

Gene therapy is an emerging therapeutic area, and Axovant Gene Therapies Ltd (NASDAQ: AXGT) is an attractive play on the sector, according to Baird. The Analyst Brian Skorney upgraded Axovant from Neutral to Outperform and lowered the price target from $16 to $13. The Thesis Axovant...

Walmart Inc (NYSE: WMT) is likely to show continued strength in multiple financial metrics when it reports second quarter earnings Thursday, Aug. 15, according to Baird. The Analyst Peter Benedict maintained an Outperform rating on Walmart with an unchanged $115 price target. The Thesis...

Target Corporation (NYSE: TGT) shares are higher by more than 25% since the start of 2019, and the stock still offers investors a compelling entry point ahead of the second-quarter print Aug. 21, according to Baird. The Analyst Peter Benedict maintained an Outperform rating on Target with an...

Twilio Inc (NYSE: TWLO) reported in-line second-quarter EPS and revenue above analyst expectations. The company also issued third-quarter guidance above consensus estimates and said it reached a $1 billion annual revenue run rate in the second quarter for the first time. Twilio is up 56% year to...

Tesla Inc (NASDAQ: TSLA) shares plummeted on Thursday after the company reported a much larger-than-expected loss in the second quarter and fell short of consensus revenue estimates as well. Tesla reiterated its full-year vehicle delivery guidance of between 360,000 and 400,000 units and once again...

Facebook, Inc. (NASDAQ: FB) reported second-quarter results that exceeded expectations. Daily active users (DAUs) of 1.59 billion and monthly active users (MAUs) were consistent with the Street's expectations, but average revenue per user (ARPU) of $7.05 beat estimates of $6.87. The company...

On Wednesday, Costco Wholesale Corporation (NASDAQ: COST) reported 5.4% same-store sales growth and 15.7% online sales growth in the month of June. Quarter after quarter, Costco continues to put up strong numbers, and its investors get rewarded. Analysts say Costco’s long-term success is no...

Bed Bath & Beyond Inc. (NASDAQ: BBBY) reported Wednesday fiscal first-quarter results, which sent the stock tumbling to its lowest level in over a decade. Here is a summary of how some of the Street's top analysts reacted to the print and management's guidance. The Analysts Wedbush'...

A potential Broadcom Inc (NASDAQ: AVGO) acquisition of Symantec Corporation (NASDAQ: SYMC) would be "very favorable" for Symantec investors, but bad for Broadcom's product innovation, according to Baird. The Analyst Jonathan Ruykhaver maintained a Neutral rating on Symantec with an...

Intellia Therapeutics Inc’s (NASDAQ: NTLA) gene editing drug seems to have the potential to disrupt the treatment of hereditary transthyretin amyloidosis, according to Baird. The Analyst Madhu Kumar initiated coverage of Intellia Therapeutics with an Outperform rating and $23 price target....

Olive Garden parent company Darden Restaurants, Inc. (NYSE: DRI) on Thursday reported fourth-quarter results. Earnings of $1.76 per share beat the analyst consensus estimate of $1.72, while quarterly sales of $2.23 billion missed the consensus estimate of $2.24 billion. Here is a summary of how...

Crocs, Inc. (NASDAQ: CROX) shares were soaring Friday after Baird turned bullish on the casual footwear company's stock.   The Analyst Jonathan Komp upgraded Crocs from Neutral to Outperform and maintained a $29 price target. The Thesis The recent pullback in Crocs shares has...

Tapestry Inc (NYSE: TPR) announced its new chief financial officer hire Wednesday. The Analyst  Baird analyst Mark Altschwager reiterated an Outperform rating on Tapestry with a $43 price target. The Thesis Joanne Crevoiserat is the luxury fashion brand's new CFO...

Tariff concerns for Yeti Holdings Inc (NASDAQ: YETI) are overblown, according to Baird.  With around 55 percent of Yeti’s sales exposed to “List-4” tariffs, the company screens unfavorably if trade tensions with China escalate further — but the analyst said ...